GKS Announces Special Program: Dashboard Support for Warning Letter Response

GKS Announces Special Program: Dashboard Support for Warning Letter Response

Rapid Regulatory Readiness At No Cost

GKS has launched a no-cost dashboard support initiative for companies that have received FDA warning letters and are within their 2-week response window. This special access is also extended to legal counsel working with affected firms, enabling fast, collaborative solutions.

About the Program

This program offers full access to GKS' dashboard tools, ensuring teams can:

• Rapidly extract and organize relevant data
• Align internal findings with regulatory expectations
• Provide defensible, data-driven responses

**Our dashboard can be integrated into your team within hours, enabling efficient, deadline-sensitive support. ****

Why Now?

Our philosophy is simple: Support teams when it matters most.

GKS is committed to helping firms build responses that are structured, clear, and timely. While this program is tailored for those managing an active warning letter, our broader goal is prevention.

We believe the best use of our dashboard is before a warning letter is issued.

That’s why this initiative doubles as an educational opportunity for legal and quality leaders to understand how GKS technology can elevate their overall compliance operations.

Access the Program Fast-Track Access